glp 1 drugs and mental health Now, new research suggests that taking a GLP-1 could have a huge impact on your health—in a good way. Before we dive in, let's address the big question: No, doctors aren't Not an 'Easy Way Out':

GLP-1RAs are one of the few glucose-lowering medications that result in weight loss, which has a robust association with improvement of hepatic steatosis [11]

NG101 is an oral, small molecule peripherally acting dopamine D2 receptor antagonist that has recently completed a proof-of-concept safety and efficacy study in nausea and vomiting associated with glucagon-like peptide 1 (GLP-1) agonists and a Ph2 trial in gastroparesis

Regulator keeps close eye on GLP-1 weight loss drugs' possible link to suicidal thoughts How will Wegovy fit into obesity societys guidelines in Korea

Stay tuned

doi: 10.1111/j.1463-1326.2011.01428.x

It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]